Open access
Sep 2026
The MAZ-POLD1 Signaling Axis Drives Cisplatin Resistance in Bladder Cancer by Activating DNA Damage Repair
This study verified that POLD1 was markedly overexpressed in cisplatin-resistant BC tissues and cells and demonstrated that POLD1 knockdown remarkably impaired DDR capacity in cisplatin-resistant BC cells and restored their chemosensitivity to cisplatin in vitro.
Biao Zhang, Hong Chang, Cheng Wang et al.
· Cancers · 0 citations